Stability and Degradation Pathways of Different Psychoactive Drugs in Neat and in Buffered Oral Fluid.


Journal

Journal of analytical toxicology
ISSN: 1945-2403
Titre abrégé: J Anal Toxicol
Pays: England
ID NLM: 7705085

Informations de publication

Date de publication:
31 Jul 2020
Historique:
received: 29 08 2019
revised: 09 10 2019
accepted: 05 11 2019
pubmed: 6 2 2020
medline: 24 9 2020
entrez: 6 2 2020
Statut: ppublish

Résumé

Sampling and drug stability in oral fluid (OF) are crucial factors when interpreting forensic toxicological analysis, mainly because samples may not be analyzed immediately after collection, potentially altering drug concentrations. Therefore, the stability of some common drugs of abuse (morphine, codeine, 6-monoacetylmorphine, cocaine, benzoylecgonine, Δ9-tetrahydrocannabinol, cannabidiol, amphetamine, 3,4-methylenedioxymethamphetamine, ketamine) and the more commonly consumed new psychoactive substances in our environment (mephedrone, and N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indazole-3-carboxamide 5F-AKB48 also known as 5F-APINACA) was investigated in an OF pool for the presence and absence of M3 Reagent Buffer® up to 1 year of storage. Fortified OF samples were stored at three different temperatures (room temperature, 4 and -20°C) to determine the best storage conditions over time. Control fortified OF samples were stored at -80°C for reference purposes. Compounds with concentration changes within ±15% of initial value were considered stable. The drugs were significantly more stable in M3 Reagent Buffer® than in neat OF samples in all storage conditions. All analytes were stable for 1 year at 4°C and -20°C in M3 Reagent Buffer®. Drugs stability in OF varied depending on the analyte, the presence of a stabilizer, the storage duration and temperature. When immediate sample analysis is not possible, we suggest to store OF samples at 4 or -20°C and test them within 2 weeks. Alternatively, OF samples may be stored at 4 or -20°C with M3 Reagent Buffer® to be tested within 1 year.

Identifiants

pubmed: 32020200
pii: 5722391
doi: 10.1093/jat/bkz114
doi:

Substances chimiques

Illicit Drugs 0
Morphine Derivatives 0
Psychotropic Drugs 0
Methamphetamine 44RAL3456C
benzoylecgonine 5353I8I6YS
Morphine 76I7G6D29C
mephedrone 8BA8T27317
Amphetamine CK833KGX7E
Cocaine I5Y540LHVR
N-Methyl-3,4-methylenedioxyamphetamine KE1SEN21RM
6-O-monoacetylmorphine M5E47P1ZCH
Codeine UX6OWY2V7J

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

570-579

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Emilia Marchei (E)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome Italy.

Sara Malaca (S)

Research Center in Health Sciences (CICS-UBI), University of Beira Interior, rua Marques de Avila e Bolama, 6299-001,Covilhã, Portugal.
Laboratory of Pharmaceutical -Toxicology - UBIMedical, University of Beira Interior, rua Marques de Avila e Bolama, 6299-001,Covilhã, Portugal.

Silvia Graziano (S)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome Italy.

Massimo Gottardi (M)

Laboratory of Toxicology, Comedical Srl., Via della Cooperazione 27, 38123, Trento, Italy and.

Simona Pichini (S)

National Centre on Addiction and Doping, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome Italy.

Francesco Paolo Busardò (FP)

Section of Legal Medicine, Università Politecnica delle Marche, Via Conca 71, 60126, Ancona, Italy.

Articles similaires

Humans Biomarkers Male Blood Coagulation Cytokines
Humans Male Methamphetamine Longitudinal Studies Sexual and Gender Minorities
Papaver Morphine Aldo-Keto Reductases Evolution, Molecular Phylogeny

Classifications MeSH